Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Acasti Pharma Inc ACST

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.


NDAQ:ACST - Post by User

Bullboard Posts
Post by simmer1965on Feb 07, 2014 11:47am
322 Views
Post# 22184243

LOL...recap of my post in Dec on NTB board +

LOL...recap of my post in Dec on NTB board +Canada defined: Home of white collar crime

Seems like mgmt forgot some budies to pass out free warrants to. This is yet another Quebec company with corrupt mgmt. They just raised 23 million and somehow they seem to be short cash? No..they forgot to include some buddies in the warrant grease. Recently saw a book at Chapters...why it's the right time to get rid of Quebec.

Here is the of my last post regarding the 23 million debacle....

https://www.stockhouse.com/companies/bullboard/t.ntb/neptune-technologies-bioressources-inc/8?postid=22005716

That was a pile of bs. Do some research. If they didn't know in July that they would need the money for the clinical trial then what were they doing? This mgmt team cannot forcast something they already have experience in doing. They are incompetent. I would like to add that the same crew decided to expand their plant in Quebec when they could have built a plant in California where whole towns are out of work. Not only that, it is 3,000 miles closer than BF Quebec to receive krill from the Antarctic. Obviously no one know anything about BCP planning. But that is obvious as it has been 10 years into next to nothing happening but more options being dished out.

The overhang would have become worse...raise the money when your stock is high jackass.

And the pricing of the units is determinedd by the market (It is not a bad market for Omega-3 stocks...ENZY is proof) and negotiated between the participants in the financing...LOL!!! That was themselves. Many shares where bought in-house and it was easy to do since they all sold shares in early September above $2.20. Not a bad way to make money sell high; buy low based on a price YOU set yourself + a freebe warrant.

Ronald Denis sold 87,500 @ 2.20 US

Andre Godin sold 10,000 @ 2.52 and 150,000 @ 2.21 US

Heri Harland sold 25,000 @ 2.21 US

Xavier Harland sold 35,000 @ 2.21 US

Claudie Lauzon sold 15,000 @ 2.21 US

Pierre Lemieux sold 75,000 @ 2.21 US

Wael Massrieh sold 20,000 @ 2.48 and 68,822 @ 2.37 US

Fotini Sampalis sold 335,000 @ 2.21 US


seekingalpha are morons. Do the proper research before you put out bs like that.
Read more at https://www.stockhouse.com/companies/bullboard/t.ntb/neptune-technologies-bioressources-inc#8rDSHC1x6flTIDFD.99



Bullboard Posts